Are adipokines the missing link between obesity, immune response, and outcomes in severe COVID-19?
Mathieu Blot, David Masson, Maxime Nguyen, Abderrahmane Bourredjem, LYMPHONIE Study Group, Pascal Andreu, François Aptel, Jérémy Barben, Guillaume Beltramo, P. Bielefeld, Philippe Bonniaud, Bernard Bonnotte, Bélaïd Bouhemad, Marielle Buisson, Pierre‐Emmanuel Charles, P. Chavanet, Auguste Dargent, Hervé Devilliers, Thomas Gauthier, Marjolaine Georges, A Guilhem, Julien Guy, Marie Labruyère, Audrey Large, Serge Monier, S. Mouriès-Martin, Jean‐Pierre Quenot, Sébastien Prin, Alain Putot, Christine Binquet, Lionel Piroth
Topics & Concepts
AdipokineMedicineLeptinAdiponectinInternal medicineObesityImmune systemCoronavirus disease 2019 (COVID-19)PneumoniaMechanical ventilationProspective cohort studyEndocrinologyImmunologyInsulin resistanceDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Adipokines, Inflammation, and Metabolic Diseases